Apr
21
2020
On demand

Scaling up viral vector manufacturing with adherent and suspension cell cultures

Sponsor
Scaling up viral vector manufacturing with adherent and suspension cell cultures

Adherent and suspension bioreactors for viral vector manufacturing are evolving. However, for each choice, a robust manufacturing process is critical to ensure it is scalable for these novel therapies to reach the patients.

One of the first steps in designing a process is whether to use adherent or suspension cell cultures. Each modality has its advantages and disadvantages. In this webinar, the panelists will outline key considerations in choosing the right technology and some of the pitfalls that must be overcome to ensure success at large scale.

Participants learn:

  • What factors to consider when choosing your cell culture
  • The advantages and pitfalls with each type of culture
  • The bioreactor choices available to support each type of culture

Clive Glover
Clive Glover
Director, Strategy at Pall Biotech
Rachel Legmann
Rachel Legmann
Senior Cell Culture Process Development Manager at Pall Biotech
Siddharth Gupta
Siddharth Gupta
Senior Bioprocess Specialist at Pall Biotech

SPEAKERS

Clive Glover
Clive Glover
Director, Strategy at Pall Biotech
Rachel Legmann
Rachel Legmann
Senior Cell Culture Process Development Manager at Pall Biotech
Siddharth Gupta
Siddharth Gupta
Senior Bioprocess Specialist at Pall Biotech

You might also like